ORTHOPEDIATRICS CORP Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Orthopediatrics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2024.
  • Orthopediatrics Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.57M, a 23.5% decline year-over-year.
  • Orthopediatrics Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$29M, a 7.51% decline year-over-year.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2023 was -$26.8M, a 5.32% decline from 2022.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2022 was -$25.4M, a 40.9% decline from 2021.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2021 was -$18M, a 32.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$29M -$5.57M -$1.06M -23.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$28M -$5.67M -$80K -1.43% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$27.9M -$9.72M -$1.13M -13.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$26.8M -$8.07M +$243K +2.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$27M -$4.51M +$2.45M +35.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$29.4M -$5.59M -$1.84M -49.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$27.6M -$8.59M -$2.21M -34.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$25.4M -$8.31M -$2.75M -49.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$22.7M -$6.96M -$3.32M -91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$19.3M -$3.74M -$897K -31.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$18.4M -$6.39M -$413K -6.91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$18M -$5.56M +$7.18M +56.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 -$25.2M -$3.64M -$1.15M -45.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$24.1M -$2.85M +$4.17M +59.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$28.2M -$5.97M -$1.48M -32.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$26.8M -$12.7M -$9.71M -320% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$17M -$2.5M -$959K -62.3% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-03
Q2 2020 -$16.1M -$7.02M -$5.23M -292% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-03
Q1 2020 -$10.9M -$4.5M -$1.78M -65.5% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-03
Q4 2019 -$9.08M -$3.03M -$1.17M -62.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$7.91M -$1.54M -$367K -31.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$7.55M -$1.79M +$330K +15.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$7.88M -$2.72M +$1.68M +38.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$9.55M -$1.87M +$2.34M +55.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$11.9M -$1.17M -$418K -55.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$11.5M -$2.12M -$1.44M -213% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$10M -$4.4M -$3.56M -425% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$6.47M -$4.2M -$952K -29.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$5.52M -$754K -$230K -43.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$5.29M -$677K +$188K +21.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$5.48M -$837K +$649K +43.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$6.13M -$3.25M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$524K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$865K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$1.49M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.